Condition

Amyloid Cardiomyopathy clinical trials and research

• 8Clinical trials
• 26Countries

Newest Amyloid Cardiomyopathy clinical trials

All recruiting trials (8)

• Acoramidis for ATTR-CM: Cardiac Imaging Study

  This study tests whether acoramidis can improve heart structure and function in people with transthyretin amyloid cardiomyopathy.

  Recruiting Phase 4 Eidos Therapeutics, a BridgeBio company · St Louis, Missouri · NCT07695701

• Hungarian National Systemic Amyloidosis Registry

  This registry collects medical data from adults with systemic amyloidosis across Hungary to help understand how the disease is diagnosed and treated in real-world practice.

  Recruiting at 12 sites Semmelweis University · Balatonfüred and 11 other locations · NCT07689331

• Cardiac MRI blood-flow imaging to distinguish types of hypertrophic cardiomyopathy

  We will try cardiac MRI perfusion imaging to see if blood-flow patterns can distinguish people with different forms of hypertrophic cardiomyopathy, including genetic carriers and related conditions like Fabry disease and cardiac amyloidosis.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, BO · NCT07382128

• Enavogliflozin for Amyloid Cardiomyopathy

  This study tests whether Enavogliflozin helps people with amyloid cardiomyopathy and heart failure by comparing it to placebo in two treatment periods.

  Recruiting at 2 sites Phase 4 Seoul St. Mary's Hospital · Seoul and 1 other locations · NCT07240844

• Investigating genistein for treating amyloid cardiomyopathy

  This study is testing if genistein can safely help people with amyloid cardiomyopathy improve their heart health and exercise ability.

  Recruiting Phase 1/2 London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · London, Ontario · NCT06634108

• Preventing transthyretin amyloidosis in young carriers of a genetic variant

  This study is testing if a medication called acoramidis can help prevent transthyretin amyloidosis in young adults who carry a specific genetic variant that puts them at risk for the disease.

  Recruiting at 104 sites Phase 3 Eidos Therapeutics, a BridgeBio company · La Jolla, California and 103 other locations · NCT06563895

• Personalized exercise program for patients with transthyretin cardiac amyloidosis

  This study is testing a personalized exercise program to see if it can help people with transthyretin cardiac amyloidosis feel stronger and improve their quality of life.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT05797857

• Registry for cardiac amyloidosis patients in Switzerland

  This study is collecting information from patients with cardiac amyloidosis in Switzerland to see how their condition changes over time and to find out who might benefit from a new treatment.

  Recruiting at 7 sites Insel Gruppe AG, University Hospital Bern · Basel and 6 other locations · NCT04776824

Related topics

Quick answers

How many Amyloid Cardiomyopathy clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 26 countries. The most sites are in United States (3 trials), Canada (2 trials), Italy (2 trials), South Korea (2 trials), Argentina (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 2, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →